FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of June 2015
Commission File Number: 001-15152
SYNGENTA AG
(Translation of registrant’s name into English)
Schwarzwaldallee 215
4058 Basel
Switzerland
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F |
X |
Form 40-F |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes | No |
X |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes | No |
X |
Indicate by check mark whether by furnishing the information contained in this Form, the Registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
Yes | No |
X |
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
SYNGENTA AG | ||||||
Date: | June 23, 2015 | By: | /s/ Sandra Bürli-Borner | |||
Name: | Dr. Sandra Bürli-Borner | |||||
Title: | Deputy Head Shareholder Services | |||||
By: | /s/ Brigitte Benz | |||||
Name: | Brigitte Benz | |||||
Title: | Head Shareholder Services & Group Administration |
|||||
Re: SYNGENTA AG
Disclosure: “Syngenta Chairman comments on Monsanto’s recent approach”
Herewith we furnish a press release related to Syngenta AG. The full text of the press release is the following:
# # #
Syngenta International AG
Media Office CH-4002 Basel Switzerland Tel: +41 61 323 2323 Fax: +41 61 323 2424
www.syngenta.com
|
Media contacts:
Paul Barrett Switzerland +41 61 323 2323
Brunswick Jon Coles/ Richard Jacques (UK) +44 207 404 5959 Monika Driscoll/Tripp Kyle (US) +1 (212) 333 3810 |
Analyst/Investor contacts:
Jennifer Gough Switzerland +41 61 323 5059 USA +1 202 737 6521
Lars Oestergaard Switzerland +41 61 323 6793 USA +1 202 737 6520 |
Basel, Switzerland, June 23, 2015
Syngenta Chairman comments on Monsanto’s recent approach
The Chairman of Syngenta’s Board of Directors, Michel Demaré, today outlined the company’s position on Monsanto’s recent approach, which was rejected for not being in the best interests of Syngenta, its shareholders and its stakeholders.
Mr Demaré’s video interview can be viewed here
Syngenta is one of the world's leading companies with more than 28,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract there for.